Bliss GVS Pharma Ltd Share Price

Q: What is the share price of Bliss GVS Pharma Ltd today?

Bliss GVS Pharma Ltd share price as on 12 Jun 2026 is ₹441.7

Pharmaceuticals

NSE: BLISSGVS Small Cap ISIN: INE416D01022

As on 13 June 2026 at 02:27 IST

₹441.70

+ 5.15

(1.18%)

Sell Buy

Over 1 Month

60.41%

Over 6 Months

197.44%

Over 1 Year

185.89%

Over 3 Years

472.15%

Bliss GVS Pharma Ltd Summary

Close ₹436.55

Open ₹427

High ₹440

Low ₹424

Volume 11,22,515

Net Turnover (in Cr) ₹48.85

52Wk High ₹462.80

52Wk Low ₹118

52Wk High / Low

118

462.80

Bliss GVS Pharma Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹4,618.22

EPS (TTM) 9.30

Book Value (BV) 109.20

Div. Yield 0.34 %

P/E (TTM) 47.60

Price/Book Value 3.99

Delivery % 45.13 %

Face Value 1

Key Ratios

PE Ratio 17.95

PB Ratio 1.17

EV to Sales 1.70

PEG Ratio 0.51

ROA 6.10

ROE 6.74

Debt-Equity 0.07

Net Profit Margin 10.34

Operating Profit Margin 19.15

Bliss GVS Pharma Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	846.22	798.98	769.37	778.95	597.43
Total Expenses	720.58	652.91	663.30	651.19	493.30
Profit Before Tax	125.64	116.87	106.07	54.17	104.13
Profit After Tax	90.26	81.58	76.73	23.13	73.97
Operating Profit After Depreciation	133.76	152.98	116.44	132.50	109.64

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	404.95	369.37	378.05	280.76	233.72
Total Non Current Assets	474.33	400.72	459.49	331.89	311.59
Total Current Assets	826.51	810.87	697.37	776.86	765.20
Total Assets	1,300.84	1,211.59	1,156.85	1,108.75	1,076.79
Total Shareholder's Fund	1,050.38	967.19	883.90	818.70	808.25

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	105.91	102.82	34.31	135.48	63.97
Net Cash Used In Investing Activities	-75.34	-83.34	-6.36	-102.90	-45.38
Net Cash Used In Financing Activities	-30.34	-20.89	-24.94	-23.73	-20.80

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	703.42	638.96	649.11	668.98	483.20
Total Expenses	609.25	527.62	533.41	545.33	392.01
Profit Before Tax	94.17	70.26	115.69	126.40	91.19
Profit After Tax	68.97	50.64	85.48	92.66	67.50
Operating Profit After Depreciation	100.75	117.15	125.75	127.98	95.38

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	367.89	329.95	324.82	224.31	174.10
Total Non Current Assets	452.01	378.04	410.04	288.22	268.98
Total Current Assets	767.69	772.23	729.65	791.74	676.64
Total Assets	1,219.70	1,150.27	1,139.69	1,079.96	945.62
Total Shareholder's Fund	1,058.63	988.44	937	851.43	755.65

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	97.21	82.17	43.81	114.05	66.97
Net Cash Used In Investing Activities	-77.73	-65.84	-12.97	-92.28	-61.62
Net Cash Used In Financing Activities	-26.71	-20.76	-26.05	-12.62	-11.67

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	256.99	218.25	244.40	207.47	197.99
Total Expenses	212.55	183.46	200.92	166.14	176.90
Profit Before Tax	44.95	40.90	40.64	63.11	23.44
Profit After Tax	37	24.78	28.59	44.36	16.65
Operating Profit after Depreciation	55.60	53.25	51.94	76.78	33.16

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	211.54	164.68	190.23	163.36	156
Total Expenses	167.39	137.83	159.96	130.60	142.28
Profit Before Tax	44.16	25.29	33.46	30.56	14.35
Profit After Tax	32.42	18.61	24.79	21.05	11.45
Operating Profit after Depreciation	53.45	37.08	43.86	43.35	23.08

Bliss GVS Pharma Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 427.03

S2 417.52

S3 411.03

Pivot 433.52

R1 443.03

R2 449.52

R3 459.03

Moving Average

20 SMA 370.86

50 SMA 303.46

100 SMA 251.02

200 SMA 204.66

Bliss GVS Pharma Ltd Corporate Actions

Bliss GVS Pharma Ltd

₹0.5/Share

Announcement Date 18 Feb 2026

Record Date 18 Feb 2026

Div Yield 50%

AGM Date: 21 Sep 2021

AGM 21/09/2021 We would like to inform you that, Board Meeting of the Company was held today i.e. Saturday, July 31, 2021 at the registered office of the Company. In pursuant to Regulation 30 and 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the Board has considered and approved the matters as per attachment. (As Per BSE Announcement Dated on 31/07/2021) Please find the attachment.(As Per BSE Announcement Dated on 9/21/2021 7:55:03 AM) Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith proceedings of the 36th Annual General Meeting held on Tuesday September 21 20201 at 11:00 am through Video Conferencing (VC)/Other Audio-Visual Means (OAVM). (As Per BSE Announcement Dated on 9/21/2021 8:04:10 AM) Please find the attachment. (As Per BSE Announcement Dated 15.09.2021) Please find the attachment. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith proceedings of the 36th Annual General Meeting held on Tuesday, September 21, 20201 at 11:00 am through Video Conferencing ('VC')/Other Audio-Visual Means ('OAVM'). In accordance with the Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclosed herewith the voting results of 36th Annual General Meeting of the Company held on Tuesday, September 21, 2021 in the prescribed format along with the report of the Scrutinizer on remote e-voting and e-voting at the 36th Annual General Meeting. (As per BSE Announcement Dated on 21/09/2021) Bliss GVS Pharma Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement dated on 22.09.2021)

AGM Date: 28 Jun 2022

Outcome Of Board Meeting Held On Saturday, April 30, 2022 37th AGM of the Company for the Financial Year 2021-2022 has been scheduled to be held on Tuesday, June 28, 2022 at 11:00 a.m. through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM') facility Pursuant to Section 91 of the Companies Act, 2013 ('Act'') and applicable Regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with our intimation submitted to you w.r.t. Final Dividend on April 30, 2022, the Register of Members and Share Transfer Books of the Company will remain closed from Wednesday, June 22, 2022 to Thursday, June 28, 2022 (both the days inclusive) for taking on record of the members of the Company for the purpose of holding 37th Annual General Meeting of the Company which will be held on Thursday, June 28, 2022 for the financial year ended March 31, 2022 and payment of Final Dividend for the financial year 2021-2022. (As Per BSE Announcement Dated on 30.04.2022) Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copy of advertisement of public notice issued in respect of information regarding 37th Annual General Meeting of the Company scheduled to be held on Tuesday, June 28, 2022 at 11:00 a.m. (IST) through Video Conferencing ('VC')/Other Audio Visual Means ('OAVM'), in compliance with the General Circulars dated April 08, 2020, April 13, 2020, May 05, 2020 and January 13, 2021, December 08, 2021, December 14, 2021 and May 05, 2022 respectively issued by the Ministry of Corporate Affairs ('MCA Circulars') along with the Circular issued by Securities and Exchange Board of India ('SEBI Circular') dated May 12, 2020, January 15, 2021 and May 13, 2022 published in Free Press Journal and Navshakti - Mumbai newspapers on May 30, 2022. (As Per BSE Announcement Dated on 30/05/2022) We would like to inform you that 37th Annual General Meeting of the Company was held today i.e. Tuesday, June 28, 2022 at 11:00 a.m., being requisite quorum present, meeting commenced at 11:00 a.m., through Video Conferencing ('VC')/Other Audio Visual Means ('OVAM') as attached herewith for your reference. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith proceedings of the 37th Annual General Meeting held on Tuesday, June 28, 2022 at 11:00 am through Video Conferencing ('VC')/Other Audio-Visual Means ('OAVM'). Kindly take the above intimation in your record. (As Per BSE Announcement Dated on 28.06.2022) In accordance with the Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclosed herewith the voting results of 37th Annual General Meeting of the Company held on Tuesday, June 28, 2022 in the prescribed format along with the report of the Scrutinizer on remote e-voting and e-voting at the 37th Annual General Meeting. (As per BSE Announcement Dated on 29/06/2022) Bliss GVS Pharma Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement dated on 30.06.2022)

AGM Date: 19 Jul 2023

Pursuant to Section 91 of the Companies Act, 2013 ('Act'') and applicable Regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with our intimation submitted to you w.r.t. Final Dividend on May 11, 2023, the Register of Members and Share Transfer Books of the Company will remain closed from Thursday, July 13, 2023 to Wednesday, July 19, 2023 (both the days inclusive) for taking on record of the members of the Company for the purpose of holding 38th Annual General Meeting of the Company which will be held on Wednesday, July 19, 2023 for the financial year ended March 31, 2023 and payment of Final Dividend for the financial year ended March 31, 2023. Please find enclosed herewith Outcome of 38th Annual General Meeting ('AGM') of the Company held today i.e. Wednesday, July 19, 2023. Please find enclosed herewith proceedings of the 38th Annual General Meeting held on Wednesday, July 19, 2023 at 11:00 a.m. through Video Conferencing ('VC')/Other Audio-Visual Means ('OVAM'). (As per BSE Announcement Dated on 19/07/2023) In accordance with the Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclosed herewith the voting results of 38th Annual General Meeting of the Company held on Wednesday, July 19, 2023 in the prescribed format along with the report of the Scrutinizer on remote e-voting and e-voting at the 38th Annual General Meeting. (As Per BSE Announcement Dated on 20/07/2023)

AGM Date: 25 Jul 2024

We would like to inform you that, the Board Meeting of the Company was held today i.e. Thursday, May 02, 2024 at the registered office of the Company. In pursuant to Regulation 30 and Regulation 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board has considered and approved the matters amongst others as attached. According to section 91 of the Companies Act, 2013 and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirments) Regulations, 2015 ('Listing Regulations'), we hereby inform you that the Register of Members and Share Transfer Books of the Company will remain closed from Friday, July 19, 2024 to Thursday, July 25, 2024 (both days inclusive) for taking on record of the members of the Company for the purpose of holding 39th Annual General Meeting of the Company which will be held on Thursday. July 25, 2024, for the financial year ended March 31, 2024 and payment of Final Dividend for the financial year ended March 31, 2024. Enclosed herewith proceedings of the 39th Annual General Meeting held on Thursday, July 25, 2024 at 11:00 a.m. through VC/OAVM. (As Per BSE Announcement Dated on: 25/07/2024)

AGM Date: 31 Jul 2025

40th Annual General Meeting ('40th AGM or AGM') of the Company for the financial year ended March 31, 2025 has been scheduled to be held on Thursday, July 31, 2025 at 11:30 A.M. According to Section 91 of the Companies Act, 2013 and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform you that the Register of Members and Share Transfer Books of the Company will remain closed from Friday, July 25, 2025 to Thursday, July 31, 2025 (both days inclusive) for 40th AGM. Please find enclosed herewith the Intimation for Book Closure for the purpose of the 40th Annual General Meeting of the Company. (As Per BSE Announcement dated on 08.07.2025) Please find attached herewith the proceedings of 40th Annual General Meeting of Bliss GVS Pharma Limited. (As Per BSE Announcement Dated on: 31/07/2025)

Bliss GVS Pharma Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Bliss GVS Pharma Ltd Top Mutal Funds Invested

Fund Name	AUM
Union Active Momentum Fund	0.77%
Bandhan BSE Healthcare Index Fund	0.19%

Bliss GVS Pharma Ltd News

Bliss GVS Pharma AGM scheduled

On 15 July 2026

13 May 2026, 09:46 am

Board of Bliss GVS Pharma recommends final dividend

Of Rs 1 per share

13 May 2026, 09:21 am

Bliss GVS Pharma to declare Quarterly Results

On 12 May 2026

06 May 2026, 11:24 am

Board of Bliss GVS Pharma recommends interim dividend

Of Rs 0.5 per share

10 Feb 2026, 03:44 pm

Bliss GVS Pharma to conduct board meeting

On 10 February 2026

04 Feb 2026, 11:52 am

Bliss GVS Pharma Ltd Stock Analysis

Annual revenue for Bliss GVS Pharma Ltd increased by 10.09% to ₹703.42 crore in FY 2025 from ₹638.96 crore in FY 2024.
Annual Net Profit for Bliss GVS Pharma Ltd increased by 36.18% to ₹68.97 crore in FY 2025 from ₹50.64 crore in FY 2024.
Promoter Shareholding in Bliss GVS Pharma Ltd remains unchanged by 0.00% in the most recent quarter, from 35.36% in December 2025 to 35.36% in March 2026.
Bliss GVS Pharma Ltd delivered a 1-year return of 185.89% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Bliss GVS Pharma Ltd share price moved up by 1.18% from its previous close of INR ₹436.55. The latest Bliss GVS Pharma Ltd share price is INR ₹441.70.
Bliss GVS Pharma Ltd share price today has been at a low of 437.20 and a high of 449.90. Over the past 52 weeks, the Bliss GVS Pharma Ltd share price has seen a low of 118 and a high of 462.80.